References
1. Torres MJ, Celik GE, Whitaker P, Atanaskovic-Markovic M, Barbaud A,
Bircher A, et al. A EAACI drug allergy interest group survey on how
European allergy specialists deal with beta-lactam allergy. Allergy.
2019;74(6):1052-62.
2. Zhou L, Dhopeshwarkar N, Blumenthal KG, Goss F, Topaz M, Slight SP,
et al. Drug allergies documented in electronic health records of a large
healthcare system. Allergy. 2016;71(9):1305-13.
3. Macy E, Ngor EW. Safely Diagnosing Clinically Significant Penicillin
Allergy Using Only Penicilloyl-Poly-Lysine, Penicillin, and Oral
Amoxicillin. The Journal of Allergy and Clinical Immunology: In
Practice. 2013;1(3):258-63.
4. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger
PA, et al. International Consensus on drug allergy. Allergy.
2014;69(4):420-37.
5. Pichler WJ, Hausmann O. Classification of Drug Hypersensitivity into
Allergic, p-i, and Pseudo-Allergic Forms. International archives of
allergy and immunology. 2016;171(3-4):166-79.
6. Trubiano JA, Adkinson NF, Phillips EJ. Penicillin Allergy Is Not
Necessarily Forever. JAMA. 2017;318(1):82-3.
7. Ricci G, Giannetti A, Belotti T, Dondi A, Bendandi B, Cipriani F, et
al. Allergy is not the main trigger of urticaria in children referred to
the emergency room. J Eur Acad Dermatol Venereol. 2010;24(11):1347-8.
8. Atanasković-Marković M, Gaeta F, Medjo B, Gavrović-Jankulović M,
Ćirković-Veličković T, Tmusic V, et al. Non-immediate hypersensitivity
reactions to beta-lactam antibiotics in children - our 10-year
experience in allergy work-up. Pediatr Allergy Immunol.
2016;27(5):533-8.
9. Macy E, Contreras R. Health care use and serious infection prevalence
associated with penicillin ”allergy” in hospitalized patients: A cohort
study. J Allergy Clin Immunol. 2014;133(3):790-6.
10. Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management
of penicillin allergy: A review. JAMA. 2019;321(2):188-99.
11. Penicillin Allergy in Antibiotic Resistance W. Penicillin Allergy
Testing Should Be Performed Routinely in Patients with Self-Reported
Penicillin Allergy. J Allergy Clin Immunol Pract. 2017;5(2):333-4.
12. Torres MJ, Romano A, Celik G, Demoly P, Khan DA, Macy E, et al.
Approach to the diagnosis of drug hypersensitivity reactions:
similarities and differences between Europe and North America. Clin
Transl Allergy. 2017;7:7.
13. Macy E, Ensina LF. Controversies in Allergy: Is Skin Testing
Required Prior to Drug Challenges? J Allergy Clin Immunol Pract.
2019;7(2):412-7.
14. Sousa-Pinto B, Blumenthal KG, Macy E, Bavbek S, Benic MS,
Alves-Correia M, et al. Diagnostic testing for penicillin allergy: A
survey of practices and cost perceptions. Allergy. 2020;75(2):436-41.
15. Mayorga C, Doña I, Perez-Inestrosa E, Fernández DT, Torres JM. The
Value of In Vitro Tests to Diminish Drug Challenges. International
Journal of Molecular Sciences. 2017;18(6).
16. Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P,
Rodrigues-Cernadas J, et al. In vitro tests for drug hypersensitivity
reactions: an ENDA/EAACI Drug Allergy Interest Group position paper.
Allergy. 2016;71(8):1103-34.
17. Blumenthal KG, Li Y, Banerji A, Yun BJ, Long AA, Walensky RP. The
Cost of Penicillin Allergy Evaluation. The journal of allergy and
clinical immunology In practice. 2018;6(3):1019-27.e2.
18. Confino-Cohen R, Rosman Y, Meir-Shafrir K, Stauber T, Lachover-Roth
I, Hershko A, et al. Oral Challenge without Skin Testing Safely Excludes
Clinically Significant Delayed-Onset Penicillin Hypersensitivity. J
Allergy Clin Immunol Pract. 2017;5(3):669-75.
19. Tucker MH, Lomas CM, Ramchandar N, Waldram JD. Amoxicillin challenge
without penicillin skin testing in evaluation of penicillin allergy in a
cohort of Marine recruits. J Allergy Clin Immunol Pract.
2017;5(3):813-5.
20. Mustafa SS, Conn K, Ramsey A. Comparing Direct Challenge to
Penicillin Skin Testing for the Outpatient Evaluation of Penicillin
Allergy: A Randomized Controlled Trial. The Journal of Allergy and
Clinical Immunology: In Practice. 2019;7(7):2163-70.
21. Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H,
et al. Guideline for the diagnosis of drug hypersensitivity reactions:
S2K-Guideline of the German Society for Allergology and Clinical
Immunology (DGAKI) and the German Dermatological Society (DDG) in
collaboration with the Association of German Allergologists (AeDA), the
German Society for Pediatric Allergology and Environmental Medicine
(GPA), the German Contact Dermatitis Research Group (DKG), the Swiss
Society for Allergy and Immunology (SGAI), the Austrian Society for
Allergology and Immunology (OGAI), the German Academy of Allergology and
Environmental Medicine (DAAU), the German Center for Documentation of
Severe Skin Reactions and the German Federal Institute for Drugs and
Medical Products (BfArM). Allergo J Int. 2015;24(3):94-105.
22. Wurpts G, Aberer W, Dickel H, Brehler R, Jakob T, Kreft B, et al.
S2k-Leitlinie: Diagnostik bei Verdacht auf eine
Betalaktamantibiotika-Überempfindlichkeit. Allergo J. 2019;28:121-51.
23. Zidarn M, Silar M, Vegnuti M, Korosec P, Kosnik M. The specificity
of tests for anti-beta-lactam IgE antibodies declines progressively with
increase of total serum IgE. Wiener klinische Wochenschrift.
2009;121(9-10):353-6.
24. Cornejo-Garcia JA, Gueant-Rodriguez RM, Torres MJ, Blanca-Lopez N,
Tramoy D, Romano A, et al. Biological and genetic determinants of atopy
are predictors of immediate-type allergy to betalactams, in Spain.
Allergy. 2012;67(9):1181-5.
25. Vultaggio A, Virgili G, Gaeta F, Romano A, Maggi E, Matucci A. High
serum β-lactams specific/total IgE ratio is associated with immediate
reactions to β-lactams antibiotics. PloS one. 2015;10(4):e0121857-e.
26. Visentin M, Lenggenhager D, Gai Z, Kullak-Ublick GA. Drug-induced
bile duct injury. Biochimica et Biophysica Acta (BBA) - Molecular Basis
of Disease. 2018;1864(4, Part B):1498-506.
27. Brockow K, Aberer W, Atanaskovic-Markovic M, Bavbek S, Bircher A,
Bilo B, et al. Drug allergy passport and other documentation for
patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy
Interest Group Position Paper. Allergy. 2016;71(11):1533-9.
28. Fellinger C, Hemmer W, Wöhrl S, Sesztak-Greinecker G, Jarisch R,
Wantke F. Clinical characteristics and risk profile of patients with
elevated baseline serum tryptase. Allergol Immunopathol (Madr).
2014;42(6):544-52.
29. Wöhrl S, Vigl K, Stingl G. Patients with drug reactions - is it
worth testing? Allergy. 2006;61(8):928-34.
30. Mayorga C, Ebo DG, Lang DM, Pichler WJ, Sabato V, Park MA, et al.
Controversies in drug allergy: In vitro testing. J Allergy Clin Immunol.
2019;143(1):56-65.
31. Salas M, Fernandez-Santamaria R, Mayorga C, Barrionuevo E, Ariza A,
Posadas T, et al. Use of the Basophil Activation Test May Reduce the
Need for Drug Provocation in Amoxicillin-Clavulanic Allergy. J Allergy
Clin Immunol Pract. 2018;6(3):1010-8.e2.
32. Diaferio L, Chiriac AM, Leoni MC, Castagnoli R, Caimmi S, Miniello
VL, et al. Skin tests are important in children with beta-lactam
hypersensitivity, but may be reduced in number. Pediatr Allergy Immunol.
2019;30(4):462-8.
33. Tannert LK, Mortz CG, Skov PS, Bindslev-Jensen C. Positive Skin Test
or Specific IgE to Penicillin Does Not Reliably Predict Penicillin
Allergy. J Allergy Clin Immunol Pract. 2017;5(3):676-83.
34. Mori F, Liccioli G, Piccorossi A, Sarti L, Barni S, Giovannini M, et
al. The Diagnosis of Ceftriaxone Hypersensitivity in a Paediatric
Population. International archives of allergy and immunology.
2019;178(3):272-6.
35. Romano A, Gaeta F, Valluzzi RL, Alonzi C, Viola M, Bousquet PJ.
Diagnosing hypersensitivity reactions to cephalosporins in children.
Pediatrics. 2008;122(3):521-7.
36. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug
provocation tests in patients with a history suggesting an immediate
drug hypersensitivity reaction. Ann Intern Med. 2004;140(12):1001-6.
37. Kränke B, Aberer W, Egger C, Hawranek T, Reider N, Volc-Platzer B,
et al. Leitlinie der Arbeitsgruppe Allergologie der ÖGDV –
Provokationstestungen zur Abklärung von unerwünschten Arzneireaktionen
an Haut und Schleimhäuten. Wiener klinische Wochenschrift.
2011;123(19-20):585-91.
38. Wöhrl S. NSAID hypersensitivity – recommendations for diagnostic
work up and patient management. Allergo Journal International.
2018;27(4):114-21.
39. Iammatteo M, Ferastraoaru D, Koransky R, Alvarez-Arango S, Thota N,
Akenroye A, et al. Identifying Allergic Drug Reactions Through
Placebo-Controlled Graded Challenges. J Allergy Clin Immunol Pract.
2017;5(3):711-7.e2.
40. Demoly P, Romano A, Botelho C, Bousquet-Rouanet L, Gaeta F, Silva R,
et al. Determining the negative predictive value of provocation tests
with beta-lactams. Allergy. 2010;65(3):327-32.
41. World Health Report. Geneva, Switzerland: World Health Organization;
2000. Available from: https://www.who.int/healthinfo/paper30.pdf.
42. Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ. Antibiotic
allergy. The Lancet. 2019;393(10167):183-98.
43. Zagursky RJ, Pichichero ME. Cross-reactivity in beta-Lactam Allergy.
J Allergy Clin Immunol Pract. 2018;6(1):72-81 e1.